BLRX
Price
$3.12
Change
+$0.20 (+6.85%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
10.78M
48 days until earnings call
PYXS
Price
$1.02
Change
+$0.10 (+10.87%)
Updated
Apr 2 closing price
Capitalization
62.82M
36 days until earnings call
Ad is loading...

BLRX vs PYXS

Header iconBLRX vs PYXS Comparison
Open Charts BLRX vs PYXSBanner chart's image
BioLineRx
Price$3.12
Change+$0.20 (+6.85%)
Volume$192
Capitalization10.78M
Pyxis Oncology
Price$1.02
Change+$0.10 (+10.87%)
Volume$515.64K
Capitalization62.82M
BLRX vs PYXS Comparison Chart
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. PYXS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Hold and PYXS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BLRX: $2.92 vs. PYXS: $0.92)
Brand notoriety: BLRX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 84% vs. PYXS: 85%
Market capitalization -- BLRX: $10.78M vs. PYXS: $62.82M
BLRX [@Biotechnology] is valued at $10.78M. PYXS’s [@Biotechnology] market capitalization is $62.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 2 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • BLRX’s TA Score: 2 bullish, 4 bearish.
  • PYXS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than BLRX.

Price Growth

BLRX (@Biotechnology) experienced а -12.57% price change this week, while PYXS (@Biotechnology) price change was -20.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

BLRX is expected to report earnings on May 21, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($62.8M) has a higher market cap than BLRX($10.8M). PYXS YTD gains are higher at: -34.615 vs. BLRX (-65.888). BLRX has higher annual earnings (EBITDA): -13.32M vs. PYXS (-64.04M). PYXS has more cash in the bank: 145M vs. BLRX (3.15M). PYXS has less debt than BLRX: PYXS (20.5M) vs BLRX (29.6M). BLRX has higher revenues than PYXS: BLRX (22M) vs PYXS (16.1M).
BLRXPYXSBLRX / PYXS
Capitalization10.8M62.8M17%
EBITDA-13.32M-64.04M21%
Gain YTD-65.888-34.615190%
P/E RatioN/AN/A-
Revenue22M16.1M137%
Total Cash3.15M145M2%
Total Debt29.6M20.5M144%
FUNDAMENTALS RATINGS
BLRX: Fundamental Ratings
BLRX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLRXPYXS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QNCX1.320.05
+3.94%
Quince Therapeutics
LKFN59.530.38
+0.64%
Lakeland Financial Corp
LOW235.281.27
+0.54%
Lowe's Companies
BERY70.550.01
+0.01%
Berry Global Group
TRML13.40-0.84
-5.90%
Tourmaline Bio

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with KURA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-1.35%
KURA - BLRX
38%
Loosely correlated
-3.33%
DWTX - BLRX
33%
Loosely correlated
-1.80%
PYXS - BLRX
31%
Poorly correlated
-6.62%
INSM - BLRX
30%
Poorly correlated
-5.62%
SNPX - BLRX
30%
Poorly correlated
+0.51%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+11.48%
KURA - PYXS
65%
Loosely correlated
+2.19%
CTMX - PYXS
39%
Loosely correlated
+4.95%
ABOS - PYXS
39%
Loosely correlated
+0.47%
BLRX - PYXS
39%
Loosely correlated
+6.16%
RXRX - PYXS
35%
Loosely correlated
+3.83%
More